Medtronic executives set to address investors at four major healthcare conferences

Thierry Piéton Executive Vice President & Chief Financial Officer Medtronic plc
Thierry Piéton Executive Vice President & Chief Financial Officer - Medtronic plc
0Comments

Medtronic plc has announced that its executives will take part in several investor conferences in September 2025. The company, which is based in Galway, Ireland, shared details of the events and who will represent the organization at each session.

Geoff Martha, chairman and chief executive officer of Medtronic, along with Thierry Piéton, executive vice president and chief financial officer, are scheduled to answer questions about the company at the 2025 Wells Fargo Healthcare Conference on Thursday, September 4.

Thierry Piéton will also speak at two other events: the Morgan Stanley 23rd Annual Global Healthcare Conference on Monday, September 8 and the BofA Global Research Global Healthcare Conference 2025 on Wednesday, September 24. At these sessions, he will respond to questions about Medtronic’s business.

Greg Smith, executive vice president of enterprise operations for Medtronic, is set to participate in the 2025 Deutsche Bank Healthcare Summit on Wednesday, September 10.

Live webcasts for each conference session will be available through the Investors Events section of Medtronic’s website (http://investorrelations.medtronic.com). Archived recordings will be posted later on the same webpage.

According to information provided by Medtronic: “Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do,we are engineering the extraordinary. For more information on Medtronic (NYSE: MDT), visit www.Medtronic.com and follow Medtronic on LinkedIn.”

The company noted that any forward-looking statements may involve risks or uncertainties described in its reports filed with the Securities and Exchange Commission.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.